Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias
- 2 June 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 157 (3), 325-331
- https://doi.org/10.1111/j.1365-2249.2009.03983.x
Abstract
Summary: A number of experimental studies have shown that natural killer (NK) cells can eliminate cancer cells and the mechanisms involved in this effect have been uncovered during the last two decades. Clinical data from haploidentical haematopoietic stem cell transplantation (haplo-HSCT) revealed that NK cells were responsible for remarkably favourable effects in both adult and paediatric high-risk leukaemias. NK receptors specific for major histocompatibility complex (MHC) class I molecules, including killer immunoglobulin (Ig)-like receptors (KIR) and CD94/NKG2A, play a major role in the anti-leukaemia effect (mediating either inhibitory or activating signals). Haplo- HSCT requires a heavy conditioning regimen for the patient and the use of large numbers of T cell-depleted HSC to be grafted. After transplantation, natural killer cells develop from HSC shortly after engraftment and may include ‘alloreactive’ NK cells that kill leukaemic cells and prevent graft-versus-host disease (GvHD). Alloreactive NK cells are characterized by the expression of KIR that are not engaged by any of the human leucocyte antigen (HLA) class I alleles expressed by the patient. Their generation is dependent upon the existence of a KIR/HLA class I mismatch between donor and recipient. Novel important information on the function and specificity of different KIR has been obtained recently by the analysis of donor-derived alloreactive NK cells in a cohort of paediatric patients given haplo-HSCT to cure acute, high-risk leukaemias.This publication has 74 references indexed in Scilit:
- Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donorBlood, 2008
- Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cellsBlood, 2008
- Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemiasImmunological Reviews, 2008
- Functions of natural killer cellsNature Immunology, 2008
- Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3The Journal of Immunology, 2008
- KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individualsInternational Immunology, 2008
- KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In VitroThe Journal of Immunology, 2007
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- Allogeneic hematopoietic transplantation and natural killer cell recognition of missing selfImmunological Reviews, 2006
- Human NK Cell Education by Inhibitory Receptors for MHC Class IImmunity, 2006